全球直接面對消費者的基因測試市場規模、佔有率、成長分析（按測試類型、按應用） - 產業預測，2024-2031 年

Global Direct-to-Consumer Genetic Testing Market Size, Share, Growth Analysis, By Test type(Ancestry testing, health & wellness testing), By Application(Personal use, medical use and forensic use) - Industry Forecast 2024-2031

出版日期: 2024年02月27日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2022年全球直接面對消費者的基因檢測市場規模估值為15.5億美元，從2023年的19.3億美元成長到2031年的112.2億美元，預計在預測期內（2024年-2031年）將成長複合年增率為24.6%。

直接面對消費者的基因檢測的全球市場正在改變人們獲取和理解基因資料的方式。這個市場使人們能夠輕鬆便捷地直接與其基因組成互動，並更多地了解他們的基因、健康風險和獨特的健康狀況。市場成長是由消費者對遺傳訊息日益成長的好奇心和自我發現的渴望所推動的。由於技術的發展和好奇心的不斷成長，基因檢測變得更加廣泛和負擔得起。此外，對個人化醫療和預防性醫療保健的日益重視也增加了對客製化遺傳見解的需求。對資料安全和隱私的擔憂正在阻礙業務擴展。由於遺傳資料是私密且敏感的，因此必須保持消費者對資料將被安全儲存和負責任地使用的信任。此外，解釋和理解基因測試結果的複雜性可能會導致客戶誤解和困惑。該領域最流行的趨勢之一是將基因檢測與穿戴式技術和數位健康平台相結合。這項合作將使人們能夠追蹤和監測遺傳健康因素，從而製定量身定做的健康干預措施。將遺傳諮詢服務納入檢測結果也是一種新趨勢，為客戶分析和利用所收集的遺傳資料提供專家建議和幫助。直接面對消費者的基因檢測市場充滿了擴張和創新的機會。資料分析和基因組研究的進步可以提高基因測試的準確性和預測能力。此外，透過增加我們測試的遺傳疾病和性狀的種類，我們可以為客戶帶來更多好處。此外，促進有關基因檢測的好處和局限性的教育和認知可以增加客戶知識並刺激市場成長。

市場概況
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 歐洲其他地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太地區
拉丁美洲
- 巴西
- 其他拉丁美洲
中東和非洲 (MEA)
- 海灣合作理事會國家
- 南非
- 其他中東/非洲

競爭格局

前5名企業對比
主要企業市場定位（2021年）
主要市場參與者所採取的策略
關鍵成功策略
近期市集活動
主要企業市場佔有率（2021年）

主要企業簡介

23andMe（US）
AncestryDNA（US）
MyHeritage（US）
FamilyTreeDNA（US）
Living DNA（UK）
Helix（US）
Color Genomics（US）
Veritas Genetics（US）
Orig3n（US）
Pathway Genomics（US）
Dante Labs（UK）
Gene by Gene（US）
Nebula Genomics（US）
GeneSight（US）
Counsyl（US）
Invitae Corporation（US）
Genomics England（UK）
Kailos Genetics（US）
African Ancestry（US）
Toolbox Genomics（US）

簡介目錄

Product Code: SQMIG35D2092

Global Direct-to-Consumer Genetic Testing Market size was valued at USD 1.55 billion in 2022 and is poised to grow from USD 1.93 billion in 2023 to USD 11.22 billion by 2031, growing at a CAGR of 24.6% during the forecast period (2024-2031).

The global market for direct-to-consumer genetic testing is transforming how people obtain and comprehend their genetic data. With the use of this market, people may easily and conveniently interact directly with their genetic makeup and learn more about their heritage, health risks, and unique wellness. Market growth is driven by consumers' growing curiosity about their genetic information and desire for self-discovery. Genetic testing is now more widely available and reasonably priced thanks to technological developments and increased curiosity. Additionally, there is a greater need for tailored genetic insights due to the growing emphasis on personalized medicine and preventive healthcare. Concern over data security and privacy is impeding business expansion. Because genetic data is private and sensitive, it is essential to preserve consumer trust that the data is stored securely and used responsibly. Furthermore, customers may misunderstand or become confused as a result of the complexity involved in interpreting and comprehending the results of genetic tests. One of the most common trends in this sector is the combination of wearable technology and digital health platforms with genetic testing. Through this connection, people can track and monitor their genetically predisposed health factors, resulting in tailored wellness interventions. Incorporating genetic counselling services with test results is another new trend that offers customers expert advice and assistance in analysing and utilizing the genetic data they have collected. The market for genetic tests sold directly to consumers offers a wealth of chances for expansion and innovation. It is possible to improve the precision and prediction ability of genetic tests thanks to developments in data analytics and genomic research. Furthermore, increasing the variety of genetic disorders and features that are tested for can benefit customers more. Furthermore, promoting education and awareness about the advantages and restrictions of genetic testing can increase customer knowledge and stimulate market growth.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Direct-to-Consumer Genetic Testing Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Direct-to-Consumer Genetic Testing Market Segmental Analysis

Global Genetic Testing Direct-to-Consumer Based on test type, application, and geography, the market is divided into segments. The market is divided into four segments based on the type of test: characteristics testing, parental testing, health and wellness testing, and ancestry testing. The market is divided into three categories based on application: forensic, medicinal, and personal. The market is divided into Latin America, Middle East and Africa, Asia Pacific, North America, and Europe.

Drivers of the Global Direct-to-Consumer Genetic Testing Market

The growing demand for individualized healthcare among consumers is a major factor driving the direct-to-consumer genetic testing market. In order to make more educated decisions about illness prevention, lifestyle modifications, and individualized treatment options, people are become more proactive about managing their health and are looking for a deeper understanding of their genetic predispositions. For instance, people can choose to undergo genetic testing to determine their likelihood of contracting inherited diseases like Alzheimer's or breast cancer, allowing them to take preventative or early detection actions.

Restraints in the Global Direct-to-Consumer Genetic Testing Market

The market for direct-to-consumer genetic testing is beset by ethical and regulatory issues. Without the assistance of healthcare professionals, consumers may misunderstand or become confused when complicated genetic information is interpreted and communicated to them. Due to the possibility of sensitive information being misused or unauthorized access due to the commercialization and accessibility of genetic information, concerns are being raised about the security and privacy of personal genetic data. Regulations are being developed by regulatory organizations to guarantee appropriate management and consumer protection in the direct-to-consumer genetic testing market.

Market Trends of the Global Direct-to-Consumer Genetic Testing Market

There is a tendency in the direct-to-consumer genetic testing business toward the expansion of applications beyond genealogy and ancestry testing. Businesses are starting to offer more and more tests that reveal information on wellness, pharmacogenomics, genetic problem carriers, and health-related features. To improve medicine selection and dosage, for example, genetic testing is now available to ascertain an individual's response to specific treatments.

Executive Summary

Market Overview
Wheel of Fortune

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Parent Market Analysis

Market Overview
Market Size
Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges

Key Market Insights

Technology Analysis
Pricing Analysis
Supply Chain Analysis
Value Chain Analysis
Ecosystem of the Market
IP Analysis
Trade Analysis
Startup Analysis
Raw Material Analysis
Innovation Matrix
Pipeline Product Analysis
Macroeconomic Indicators
Top Investment Analysis
Key Success Factor
Degree of Competition

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Regulatory Landscape
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact

Global Direct-to-Consumer Genetic Testing Market by Test type

Market Overview
Ancestry testing
health & wellness testing
traits testing
and parental testing

Global Direct-to-Consumer Genetic Testing Market by Application

Market Overview
Personal use
medical use and forensic use

Global Direct-to-Consumer Genetic Testing Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2021
Strategies Adopted by Key Market Players
Top Winning Strategies
- By Development
- By Company
- By Year
Recent Activities in the Market
Key Companies Market Share (%), 2021

Key Company Profiles

23andMe (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AncestryDNA (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MyHeritage (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
FamilyTreeDNA (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Living DNA (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Helix (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Color Genomics (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Veritas Genetics (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Orig3n (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pathway Genomics (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Dante Labs (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Gene by Gene (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nebula Genomics (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GeneSight (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Counsyl (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Invitae Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Genomics England (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Kailos Genetics (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
African Ancestry (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Toolbox Genomics (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments